Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Azactam 1g Powder for Solution for Injection or Infusion – PA0002/052/002
- Azactam 2g Powder for Solution for Injection or Infusion – PA0002/052/003
- Bricanyl Turbohaler 500mcg per metred dose inhalation powder – PA1019/007/002
- One-Alpha 0.25mcg Soft Capsule – PA0046/024/002
- Perindopril tosilate/Amlodipine Teva 5mg/10mg Tablet – PA0749/197/002
- Valaciclovir Teva 500mg Film Coated Tablet – PA0749/036/001
- Vancomycin 1000mg Powder for Concentrate for Solution for Infusion and Oral Solution – PA1122/008/002
- Xanax 250mcg Tablet – PA0822/141/002
- Zineryt 40mg +12mg Powder and Solvent for Cutaneous Solution – PA0046/065/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Actelsar HCT 80/25mg Tablet – EU/1/13/817/029-041
- Propofol-Lipuro 1% (10mg/ml) Emulsion for Injection or Infusion (100ml presentation) – PA0736/018/002
- Sastravi 100/25/200mg Film Coated Tablet – PA1380/154/003
- Septrin Forte 160mg/800mg Tablet – PA1691/010/002
- Vepesid 100mg Capsule – PA2255/004/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.